Publications (23)

¹ Publicaciones consideradas como producción del grupo

View referenced research data.

filter_list Neurology

2025

  1. An MRI assessment of mechanisms underlying lesion growth and shrinkage in multiple sclerosis

    Annals of Clinical and Translational Neurology, Vol. 12, Núm. 4, pp. 686-700

2024

  1. Clinical Manifestations

    Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol. 20, pp. e090671

  2. Clinical Manifestations

    Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol. 20, pp. e092396

  3. Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis

    Annals of Neurology, Vol. 96, Núm. 2, pp. 276-288

  4. Improving criteria for dissemination in space in multiple sclerosis by including additional regions

    Annals of Clinical and Translational Neurology, Vol. 11, Núm. 10, pp. 2572-2582

  5. Improving explanation of motor disability with diffusion-based graph metrics at onset of the first demyelinating event

    Multiple Sclerosis Journal, Vol. 30, Núm. 7, pp. 800-811

  6. Investigating the relationship between thalamic iron concentration and disease severity in secondary progressive multiple sclerosis using quantitative susceptibility mapping: Cross-sectional analysis from the MS-STAT2 randomised controlled trial

    NeuroImage: Reports, Vol. 4, Núm. 3

  7. Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments

    Journal of Magnetic Resonance Imaging, Vol. 59, Núm. 6, pp. 2192-2201

  8. Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein–associated disease

    Multiple Sclerosis Journal, Vol. 30, Núm. 6, pp. 674-686

  9. The evolving contribution of MRI measures towards the prediction of secondary progressive multiple sclerosis

    Journal of Neurology, Neurosurgery and Psychiatry

  10. Treatment reduces the incidence of newly appearing multiple sclerosis lesions evolving into chronic active, slowly expanding lesions: A retrospective analysis

    European Journal of Neurology, Vol. 31, Núm. 1

  11. What contributes to disability in progressive MS? A brain and cervical cord–matched quantitative MRI study

    Multiple Sclerosis Journal, Vol. 30, Núm. 4-5, pp. 516-534

  12. White Matter Magnetic Resonance Diffusion Measures in Multiple Sclerosis with Overactive Bladder †

    Brain Sciences, Vol. 14, Núm. 10

2023

  1. Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome

    Alzheimer's and Dementia, Vol. 19, Núm. 11, pp. 4817-4827

  2. Commercial volumetric MRI reporting tools in multiple sclerosis: a systematic review of the evidence

    Neuroradiology, Vol. 65, Núm. 1, pp. 5-24

  3. Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging

    Neurology, Vol. 100, Núm. 3, pp. E308-E323

  4. Diffusion tensor imaging metrics associated with future disability in multiple sclerosis

    Scientific Reports, Vol. 13, Núm. 1

  5. Diffusion-based structural connectivity patterns of multiple sclerosis phenotypes

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 94, Núm. 11, pp. 916-923

  6. Genetic influences on disease course and severity, 30 years after a clinically isolated syndrome

    Brain Communications, Vol. 5, Núm. 5

  7. HLA-DRB1*1501 influences long-term disability progression and tissue damage on MRI in relapse-onset multiple sclerosis

    Multiple Sclerosis Journal, Vol. 29, Núm. 3, pp. 333-342